Publications by authors named "Claire Mathiot"

Claim this Profile
E
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.
Maroulio Pertesi, Maxime Vallée, Xiaomu Wei, Maria V Revuelta, Perrine Galia, Claire Mathiot

Leukemia· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.
Philippe Moreau, Michel Attal, Cyrille Hulin, Bertrand Arnulf, Karim Belhadj, Claire Mathiot

Lancet· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma.
Laurent Garderet, Frederique Kuhnowski, Benoit Berge, Murielle Roussel, Martine Escoffre-Barbe, Claire Mathiot

Blood· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma.
Guillemette Fouquet, Lionel Karlin, Margaret Macro, Denis Caillot, Murielle Roussel, Claire Mathiot

Ann Hematol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Clinical research activity of the French cancer cooperative network: Overview and perspectives].
Claire Dubois, Franck Morin, Denis Moro-Sibilot, Alexandra Langlais, Jean-François Seitz, Claire Mathiot

Bull Cancer· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma.
Michel Attal, Valerie Lauwers-Cances, Cyrille Hulin, Xavier Leleu, Denis Caillot, Claire Mathiot

N Engl J Med· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of chronic lymphocytic leukemia in Senegal.
Abibatou Sall, Awa Oumar Touré, Fatimata Bintou Sall, Moussa Ndour, Seynabou Fall, Claire Mathiot

BMC Hematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial.
Philippe Rodon, Cyrille Hulin, Brigitte Pegourie, Mourad Tiab, Bruno Anglaret, Claire Mathiot

Haematologica· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial results.
Xavier Leleu, Lionel Karlin, Margaret Macro, Cyrille Hulin, Laurent Garderet, Claire Mathiot

Blood· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
Eileen M Boyle, Guillemette Fouquet, Stéphanie Guidez, Sarah Bonnet, Helene Demarquette, Claire Mathiot

Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs.
Xavier Leleu, Philippe Rodon, Cyrille Hulin, Laurent Daley, Charles Dauriac, Claire Mathiot

Thromb Haemost· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02.
Xavier Leleu, Michel Attal, Bertrand Arnulf, Philippe Moreau, Catherine Traulle, Claire Mathiot

Blood· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survival.
Hervé Avet-Loiseau, Michel Attal, Loic Campion, Denis Caillot, Cyrille Hulin, Claire Mathiot

J Clin Oncol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.
Michel Attal, Valerie Lauwers-Cances, Gerald Marit, Denis Caillot, Philippe Moreau, Claire Mathiot

N Engl J Med· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer.
Benjamin Besse, David Planchard, Anne-Sophie Veillard, Laurent Taillade, David Khayat, Claire Mathiot

Lung Cancer· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study.
François-Clément Bidard, David Hajage, Thomas Bachelot, Suzette Delaloge, Etienne Brain, Claire Mathiot

Breast Cancer Res· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma.
Philippe Moreau, Herve Avet-Loiseau, Thierry Facon, Michel Attal, Mourad Tiab, Claire Mathiot

Blood· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial.
Philippe Moreau, Michel Attal, Brigitte Pégourié, Lucie Planche, Cyrille Hulin, Claire Mathiot

Blood· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?
Hervé Avet-Loiseau, Florent Malard, Loic Campion, Florence Magrangeas, Catherine Sebban, Claire Mathiot

Blood· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma.
Laurence Lodé, Marion Eveillard, Valérie Trichet, Thierry Soussi, Soraya Wuillème, Claire Mathiot

Haematologica· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p).
Hervé Avet-Loiseau, Xavier Leleu, Murielle Roussel, Philippe Moreau, Catherine Guerin-Charbonnel, Claire Mathiot

J Clin Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.
Jean-Luc Harousseau, Michel Attal, Hervé Avet-Loiseau, Gerald Marit, Denis Caillot, Claire Mathiot

J Clin Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular adnexal lymphoma and Helicobacter pylori gastric infection.
Didier Decaudin, Agnès Ferroni, Anne Vincent-Salomon, Kheira Beldjord, Pierre Validire, Claire Mathiot

Am J Hematol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays.
Antoine-Emmanuel Saliba, Laure Saias, Eleni Psychari, Nicolas Minc, Damien Simon, Claire Mathiot

Proc Natl Acad Sci U S A· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM).
Murielle Roussel, Philippe Moreau, Anne Huynh, Jean-Yves Mary, Clotaire Danho, Claire Mathiot

Blood· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis